GeneBioTech Co. ,Ltd (KOSDAQ:086060)
South Korea · Delayed Price · Currency is KRW 5,030.00
+260.00 (5.45%)
At close: Feb 13, 2026
GeneBioTech Co. ,Ltd Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 3,682 | 2,865 | 2,591 | 1,523 | -484.4 | -2,341 |
Depreciation & Amortization | 1,379 | 1,368 | 1,338 | 1,286 | 1,244 | 2,047 |
Loss (Gain) From Sale of Assets | -32.53 | -122.26 | -20.69 | 0 | 5.88 | 1,194 |
Asset Writedown & Restructuring Costs | - | - | 589.54 | - | - | - |
Provision & Write-off of Bad Debts | -45.68 | -96.12 | -27.83 | 36.83 | 31.96 | 230.15 |
Other Operating Activities | 1,119 | 797.55 | 1,066 | 284.17 | 155.03 | 1,240 |
Change in Accounts Receivable | -2,497 | -1,662 | 2,464 | -3,955 | -3,602 | 469.97 |
Change in Inventory | 3,858 | -2,239 | 650.04 | -1,806 | -3,390 | -189.74 |
Change in Accounts Payable | 624.58 | -193.85 | -336.71 | -813.24 | 3,088 | 348.46 |
Change in Unearned Revenue | - | - | - | - | -1.96 | -0.13 |
Change in Income Taxes | -34.51 | - | -15.88 | 118.62 | 136.36 | -61.06 |
Change in Other Net Operating Assets | -2,402 | -1,182 | -929.93 | -353.49 | 103.98 | -445.8 |
Operating Cash Flow | 5,651 | -463.87 | 7,369 | -3,679 | -2,713 | 2,492 |
Operating Cash Flow Growth | 162.99% | - | - | - | - | - |
Capital Expenditures | -4,225 | -1,100 | -530.02 | -1,155 | -3,102 | -4,386 |
Sale of Property, Plant & Equipment | 35.69 | 224.62 | 23.14 | - | 6.36 | 59.63 |
Cash Acquisitions | - | - | - | - | - | -208.08 |
Sale (Purchase) of Intangibles | -2.04 | -82.71 | -236.9 | -18.91 | -12.28 | 91.4 |
Investment in Securities | 770.96 | 124.03 | -4,608 | 1,685 | 8,397 | 3,245 |
Other Investing Activities | 50.08 | 16.96 | -31.71 | -5.9 | 211.41 | 371.36 |
Investing Cash Flow | -3,533 | -1,030 | -5,326 | 649.96 | 5,745 | -703.78 |
Short-Term Debt Issued | - | 16,673 | 12,398 | 17,015 | 14,232 | 11,282 |
Long-Term Debt Issued | - | 1,830 | 2,200 | 1,375 | 1,000 | 155.22 |
Total Debt Issued | 18,795 | 18,503 | 14,598 | 18,390 | 15,232 | 11,437 |
Short-Term Debt Repaid | - | -13,841 | -14,013 | -15,237 | -10,623 | -9,454 |
Long-Term Debt Repaid | - | -1,686 | -1,298 | -117.76 | -2,984 | -224.57 |
Total Debt Repaid | -20,985 | -15,527 | -15,311 | -15,355 | -13,608 | -9,679 |
Net Debt Issued (Repaid) | -2,190 | 2,976 | -712.61 | 3,035 | 1,625 | 1,759 |
Dividends Paid | - | - | - | - | -258.32 | -258.32 |
Other Financing Activities | - | - | 0 | - | -5,820 | -94.08 |
Financing Cash Flow | -2,190 | 2,976 | -712.61 | 3,035 | -4,453 | 1,406 |
Foreign Exchange Rate Adjustments | 66.99 | 46.92 | -9.59 | -6 | 57.42 | -23.85 |
Miscellaneous Cash Flow Adjustments | - | - | -0 | - | - | -0 |
Net Cash Flow | -4.81 | 1,529 | 1,321 | -0.08 | -1,364 | 3,170 |
Free Cash Flow | 1,426 | -1,564 | 6,838 | -4,834 | -5,816 | -1,895 |
Free Cash Flow Growth | -14.66% | - | - | - | - | - |
Free Cash Flow Margin | 1.55% | -1.89% | 8.60% | -5.84% | -9.26% | -3.21% |
Free Cash Flow Per Share | 165.61 | -181.68 | 794.19 | -561.41 | -675.39 | -220.06 |
Cash Interest Paid | 616.85 | 621.87 | 177.07 | 181.39 | 36.97 | 94.08 |
Cash Income Tax Paid | 461.04 | 418.01 | 216.78 | -141.85 | 386.84 | 314.69 |
Levered Free Cash Flow | -617.28 | -3,064 | 5,514 | -5,633 | -5,825 | -6,058 |
Unlevered Free Cash Flow | -246.91 | -2,662 | 5,877 | -5,460 | -5,730 | -6,058 |
Change in Working Capital | -451.1 | -5,277 | 1,832 | -6,810 | -3,666 | 121.71 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.